statistiche ricercatore

DENTALI, FRANCESCO

Distribuzione geografica

Continente	#
NA - Nord America	35.075
EU - Europa	16.158
AS - Asia	12.470
SA - Sud America	1.477
Continente sconosciuto - Info sul continente non disponibili	591
AF - Africa	232
OC - Oceania	16
Totale	66.019

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	34.589
IT - Italia	7.447
SG - Singapore	4.060
CN - Cina	2.624
UA - Ucraina	2.305
TR - Turchia	1.663
VN - Vietnam	1.600
HK - Hong Kong	1.450
SE - Svezia	1.241
DE - Germania	1.216
BR - Brasile	1.196
IE - Irlanda	808
FI - Finlandia	724
GB - Regno Unito	714
FR - Francia	670
RU - Federazione Russa	508
BD - Bangladesh	336
CA - Canada	228
IN - India	228
MX - Messico	156
NL - Olanda	107
JP - Giappone	101
AR - Argentina	93
ES - Italia	79
PL - Polonia	74
IQ - Iraq	66
ZA - Sudafrica	66
AT - Austria	62
NG - Nigeria	42
PK - Pakistan	42
EC - Ecuador	37
LT - Lituania	36
BE - Belgio	35
CO - Colombia	35
ID - Indonesia	32
CL - Cile	29
EU - Europa	29
VE - Venezuela	29
MA - Marocco	28
SA - Arabia Saudita	28
UZ - Uzbekistan	26
MY - Malesia	24
CZ - Repubblica Ceca	22
KE - Kenya	21
IL - Israele	20
JM - Giamaica	20
PH - Filippine	20
AE - Emirati Arabi Uniti	19
JO - Giordania	18
PY - Paraguay	18
NP - Nepal	17
CR - Costa Rica	16
HN - Honduras	16
AU - Australia	15
EG - Egitto	15
MD - Moldavia	15
RO - Romania	14
BO - Bolivia	13
GR - Grecia	13
PE - Perù	13
TN - Tunisia	13
UY - Uruguay	13
CH - Svizzera	12
GT - Guatemala	12
PT - Portogallo	12
TH - Thailandia	12
AZ - Azerbaigian	10
DZ - Algeria	10
IR - Iran	10
KR - Corea	10
TT - Trinidad e Tobago	9
AL - Albania	8
ET - Etiopia	8
SN - Senegal	8
TW - Taiwan	8
CI - Costa d'Avorio	7
LB - Libano	7
DO - Repubblica Dominicana	6
HU - Ungheria	6
KZ - Kazakistan	6
OM - Oman	6
RS - Serbia	6
SV - El Salvador	6
AO - Angola	4
BA - Bosnia-Erzegovina	4
KW - Kuwait	4
MK - Macedonia	4
NI - Nicaragua	4
NO - Norvegia	4
XK - ???statistics.table.value.countryCode.XK???	4
A2 - ???statistics.table.value.countryCode.A2???	3
AM - Armenia	3
DK - Danimarca	3
GE - Georgia	3
PA - Panama	3
BB - Barbados	2
BH - Bahrain	2
BN - Brunei Darussalam	2
BY - Bielorussia	2
DM - Dominica	2
Totale	65.426

Salva come PNG Salva come JPEG

Città	#
Milan	5.081
Fairfield	4.108
Ashburn	2.863
San Jose	2.705
Woodbridge	2.671
Singapore	2.219
Houston	1.962
Jacksonville	1.809
Seattle	1.614
Wilmington	1.506
Hong Kong	1.432
Chandler	1.387
Cambridge	1.385
Ann Arbor	1.312
Dallas	897
Izmir	816
Dublin	802
Princeton	788
Council Bluffs	743
The Dalles	674
Dearborn	591
Beijing	543
Nyköping	539
Boardman	504
Lauterbourg	421
Dong Ket	367
Chicago	360
Rome	357
Ho Chi Minh City	315
Munich	301
Los Angeles	297
New York	291
San Diego	248
Santa Clara	232
Helsinki	203
London	199
Hanoi	196
San Mateo	159
Ogden	153
São Paulo	135
Como	127
Orem	122
Washington	114
Guangzhou	107
Mexico City	100
Tokyo	83
Buffalo	81
Nuremberg	79
Montreal	76
Frankfurt am Main	74
Düsseldorf	71
Chennai	68
Hefei	65
Shanghai	65
Brooklyn	64
Phoenix	62
Redmond	62
Nanjing	60
Verona	59
Warsaw	57
Atlanta	56
Kunming	55
Turku	55
Denver	54
Norwalk	54
Salt Lake City	53
San Francisco	53
Tianjin	53
Hangzhou	51
Manchester	48
Toronto	46
Paris	45
Shenzhen	45
Haiphong	44
Boston	42
Amsterdam	41
Stockholm	41
Abuja	39
Johannesburg	39
Kocaeli	39
Rio de Janeiro	38
Varese	38
Belo Horizonte	34
Elk Grove Village	34
Jinan	34
Philadelphia	34
Da Nang	31
Poplar	31
Kilburn	30
Mumbai	30
Brussels	29
Columbus	29
Tampa	28
Nanchang	27
Zhengzhou	27
Tashkent	24
Baghdad	22
Changsha	22
Memphis	22
Vienna	22
Totale	46.320

Salva come PNG Salva come JPEG

Nome	#
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both	408
Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: A systematic review and meta-analysis of the literature	380
Vitamin K antagonists in the era of direct oral anticoagulants: is there still a room for their use?	328
A survey of thrombosis prophylaxis use in patients undergoing arthroscopic surgery	314
Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis	310
A clinical score to rule out the concomitant presence of deep vein thrombosis in patients presenting with superficial vein thrombosis: The ICARO study	309
Warfarin interactions with antibiotics in the ambulatory care setting	298
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment	275
Effect of Vitamin K Intake on the Stability of Treatment with Vitamin K Antagonists: A Systematic Review of the Literature	273
Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19	267
ABO blood group and vascular disease: an update	261
Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry	260
Pulmonary Embolism Severity Index Accurately Predicts Long-Term Mortality Rate In Patients Hospitalized For Acute Pulmonary Embolism	259
Risk of recurrence of unusual site venous thromboembolism	259
Optimal treatment duration of venous thrombosis	253
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature	250
Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment	248
Risk factors for suboptimal efficacy of 3-factor prothrombin complex concentrates in emergency vka anticoagulation reversal	245
PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis	242
incidence of thromboembolic complications in patients with mechanical heart valves with a subtherapeutic international normalized ratio.	240
Association between ABCG2 and ABCB1 genes and warfarin stability: a case-control study	236
Unsuspected pulmonary embolism in cancer patients: a narrative review with pooled data	234
Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome	234
A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program.	233
A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism	232
Diagnosis and management of venous thromboembolism: Results of a survey on current clinical practice	231
Venous ischemic syndromes	231
Diagnostic accuracy of lung ultrasound for pulmonary embolism: a systematic review and meta-analysis.	228
Prevalence and Clinical History of Incidental, Asymptomatic Pulmonary Embolism: A Meta-Analysis	228
Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy	226
Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism	225
Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism.	224
Patient selection for thromboprophylaxis in medical inpatients	224
Role of ABO blood group and of other risk factors on the presence of residual vein obstruction after deep-vein thrombosis	221
Inferior vena cava filter in patients with venous thromboembolism and major bleeding events: building the evidence	221
Abdominal obesity and the risk of recurrent deep vein thrombosis.	218
Presence of residual thromboemboli at least six months after a first episode of symptomatic pulmonary embolism: do perfusion scintigraphy and angio-computed tomography agree?	218
Metabolic syndrome and hyperhomocysteinemia in patients with deep vein thrombosis: a case-control study	217
Venous and arterial thrombosis in patients with HIV infection	216
Major Bleeding and Case Fatality Rate with the Direct Oral Anticoagulants in Orthopedic Surgery: A Systematic Review and Meta-Analysis	216
Statins, fibrates, and venous thromboembolism: a meta-analysis.	215
Duration of anticoagulation after venous thromboembolism in real world clinical practice	215
Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature	214
Prognostic stratification of chronic heart failure in elderly population: are cardiopulmonary tests and BNP really valuable?	211
Prognostic role of neutrophils to lymphocytes ratio in patients with acute pulmonary embolism: a systematic review and meta-analysis of the literature	211
Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: A multicenter retrospective cohort study	210
Atypical case of Acute Coronary Syndrome due to Coronary-Pulmonary Steal Syndrome secondary to Pulmonary Embolism.	209
Pulmonary embolism prognostic factors and length of hospital stay: A cohort study	209
The role of inherited thrombophilia in patients with isolated pulmonary embolism: a systematic review and a meta-analysis of the literature	208
Predictors of residual venous obstruction after deep vein thrombosis of the lower limbs: a prospective cohort study	207
Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes	207
Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens	205
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation	205
Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy	205
Seasonal and monthly variation in occurrence of hypertensive urgency	203
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage	201
Diagnostic accuracy of magnetic resonance imaging in patients with suspected pulmonary embolism: A bivariate meta-analysis	201
Prevention and treatment of venous thromboembolism in patients with solid brain neoplasms: results of a survey among Italian physicians	201
Statins and secondary prevention of ischemic and hemorrhagic stroke	199
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature: a reply to a rebuttal	199
Brain natriuretic peptide and preclinical chronic thromboembolic pulmonary hypertension.	198
Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature	198
Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding	197
Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases	196
Statins for acute ischemic stroke	196
Abdominal pain as pulmonary embolism presentation, usefulness of bedside ultrasound: A report of two cases	196
In vitro effects of Apixaban on 5 different cancer cell lines	196
sRAGE and early signs of cardiac target organ damage in mild hypertensives	196
Risk of Thromboembolism, Recurrent Hemorrhage, and Death after Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding	196
Risk of bleeding in low-risk atrial fibrillation patients on warfarin waiting for elective cardioversion.	195
Italian intersociety consensus on DOAC use in internal medicine	195
Prevalence of renal failure and use of antithrombotic prophylaxis among medical inpatients at increased risk of venous thromboembolic events.	193
An unusual case of cerebral vein thrombosis in a patient with giant cell arteritis	193
Factors associated with anticoagulation prescription in elderly patients with atrial fibrillation	193
Rapid salivary test suitable for a mass screening program to detect SARS-CoV-2: a diagnostic accuracy study	193
5 flourouracil-induced apical ballooning syndrome: a case report.	192
Is diabetes a hypercoagulable state? A critical appraisal	192
Neutrophil-to-lymphocyte ratio: A new prognostic factor even in patients with heart failure	192
Management of primary care patients with suspected deep vein thrombosis: use of a therapeutic dose of low-molecular-weight heparin to avoid urgent ultrasonographic evaluation.	192
Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry.	191
Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: A systematic review and meta-analysis	191
Mild antithrombin deficiency and risk of recurrent venous thromboembolism: a prospective cohort study	190
Clinical utility of antithrombotic prophylaxis in ART procedures: an Italian experience	190
A CLINICAL ASSESSMENT MODEL TO SELECT ELDERLY PATIENTS WITH CHRONIC ATRIAL FIBRILLATION FOR A SAFE WARFARIN TREATMENT	189
How I treat splanchnic vein thrombosis	189
The role of thrombolytic therapy in pulmonary embolism	189
Low-molecular -weight heparin in pregnancies after ART -A retrospective study-	189
External validation of the DASH prediction rule: a retrospective cohort study	189
Clinical Pregnancies and Live Births in women approaching ART: a follow-up analysis of 157 women after thrombophilia screening	188
Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE Study	188
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis.	188
Prevention of in-hospital VTE: why can't we do better?	187
Low ankle-brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events	186
Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs	186
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy	186
General practitioner–performed compression ultrasonography for diagnosis of deep vein thrombosis of the leg: A multicenter, prospective cohort study	186
Atypical case of acute coronary syndrome due to coronary-pulmonary steal syndrome secondary to pulmonary embolism.	185
The effect of thyroid autoantibodies on warfarin stability	185
Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action.	185
The prevention and treatment of venous thromboembolism in pregnancy	185
Totale	21.968

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	290.220
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	290.220

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	3.630	0	544	187	104	219	172	325	215	229	726	411	498
2022/2023	4.390	480	206	318	379	303	956	14	576	652	244	140	122
2023/2024	8.221	1.245	1.282	1.286	1.563	1.639	574	66	119	241	95	43	68
2024/2025	6.800	46	52	1.123	178	236	465	373	543	743	705	584	1.752
2025/2026	16.659	1.049	1.000	917	1.983	1.355	881	3.629	1.101	2.024	1.139	948	633
2026/2027	1.555	495	1.060	0	0	0	0	0	0	0	0	0	0
Totale													66.019